Cliniexperts Completes Akynzeo Phase IV Study for Glenmark
Cliniexperts successfully concludes Phase IV study of Glenmark's Akynzeo for CINV prevention. Breakthrough in cancer care with proven efficacy and safety results.
Category : Search result: AI in pharmaceuticals
India, Slovenia Discuss Trade and Investment Promotion
India and Slovenia explored strengthening trade, investment, and sectoral cooperation in agriculture, pharma, energy, and more. Discover the key outcomes.
SMS Pharma Shares Jump 17% After USFDA Nod for Ranitidine
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
India GCCs Focus on Innovation Over Scale in AI Era
India's Global Capability Centres are shifting from hiring numbers to innovation-driven outcomes. Pharma and fintech leaders reveal bold strategies prioritizing AI and blockchain over cost arbitrage.
Balaxi Pharma Soars 10% Despite 47% Yearly Loss
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
Atorvastatin Recall: Cholesterol Drug Safety Alert
Critical drug recall affects millions of Indians taking Atorvastatin. Learn about the safety concerns, batch numbers, and what immediate steps you should take if you're on cholesterol medication.
Page 1 of 1